BioVie Inc. Operating Cash Flow
BioVie Inc. (BIVI) reported Operating Cash Flow of -$19.02 million for the 12-month period ending 2026-06-30, per its 10-K filed 2026-08-13.
Financial Statements › Cash Flow › Operating Activities
us-gaap:NetCashProvidedByUsedInOperatingActivities · last filed 2026-08-13
- BioVie Inc. net cash provided by (used in) operating activities for the quarter ending 2026-06-30 was -$4.12M.
- BioVie Inc. net cash provided by (used in) operating activities for the quarter ending 2026-03-31 was -$7.44M.
- BioVie Inc. net cash provided by (used in) operating activities for the quarter ending 2025-12-31 was -$4.44M.
- BioVie Inc. net cash provided by (used in) operating activities for the quarter ending 2025-09-30 was -$3.02M.
- BioVie Inc. net cash provided by (used in) operating activities for fiscal 2026 was -$19.02M.
- BioVie Inc. net cash provided by (used in) operating activities for fiscal 2025 was -$19.03M.
- BioVie Inc. net cash provided by (used in) operating activities for fiscal 2023 was -$40.25M.
- BioVie Inc. net cash provided by (used in) operating activities for fiscal 2022 was -$18.99M.
| Period end | Net Cash Provided by (Used in) Operating Activities 3 month | Net Cash Provided by (Used in) Operating Activities 3 month as first filed | Net Cash Provided by (Used in) Operating Activities 6 month | Net Cash Provided by (Used in) Operating Activities 6 month as first filed | Net Cash Provided by (Used in) Operating Activities 9 month | Net Cash Provided by (Used in) Operating Activities 9 month as first filed | Net Cash Provided by (Used in) Operating Activities 12 month | Net Cash Provided by (Used in) Operating Activities 12 month as first filed |
|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | -$4.12M derived: 10-K 12 month − S-1/A 9 month · filed 2026-08-13 | -$11.56M derived: sum of 2 quarters · filed 2026-08-13 | -$16.00M derived: sum of 3 quarters · filed 2026-08-13 | -$19.02M 10-K · filed 2026-08-13 | ||||
| 2026-03-31 | -$7.44M derived: S-1/A 9 month − 10-Q 6 month · filed 2026-08-06 | -$11.88M derived: sum of 2 quarters · filed 2026-08-06 | -$14.90M S-1/A · filed 2026-08-06 | -$20.51M derived: sum of 4 quarters · filed 2026-08-13 | ||||
| 2025-12-31 | -$4.44M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-02-06 | -$7.46M 10-Q · filed 2026-02-06 | -$13.07M derived: sum of 3 quarters · filed 2026-08-13 | -$14.32M derived: sum of 4 quarters · filed 2026-08-13 | ||||
| 2025-09-30 | -$3.02M 10-Q · filed 2025-11-10 | -$8.63M derived: sum of 2 quarters · filed 2026-08-13 | -$9.88M derived: sum of 3 quarters · filed 2026-08-13 | -$18.47M derived: sum of 4 quarters · filed 2026-08-13 | ||||
| 2025-06-30 | -$5.61M derived: 10-K 12 month − S-1/A 9 month · filed 2026-08-13 | -$6.86M derived: sum of 2 quarters · filed 2026-08-13 | -$15.45M derived: sum of 3 quarters · filed 2026-08-13 | -$19.03M 10-K · filed 2026-08-13 | ||||
| 2025-03-31 | -$1.25M derived: S-1/A 9 month − 10-Q 6 month · filed 2026-08-06 | -$9.84M derived: sum of 2 quarters · filed 2026-08-06 | -$13.42M S-1/A · filed 2026-08-06 | -$17.42M derived: sum of 4 quarters · filed 2026-08-06 | ||||
| 2024-12-31 | -$8.58M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-02-06 | -$12.16M 10-Q · filed 2026-02-06 | -$16.17M derived: sum of 3 quarters · filed 2026-08-06 | -$22.02M derived: sum of 4 quarters · filed 2026-08-06 | ||||
| 2024-09-30 | -$3.58M 10-Q · filed 2025-11-10 | -$7.59M derived: sum of 2 quarters · filed 2026-08-06 | -$13.44M derived: sum of 3 quarters · filed 2026-08-06 | -$19.35M derived: sum of 4 quarters · filed 2026-08-06 | ||||
| 2024-06-30 | -$4.01M derived: S-1/A 12 month − 10-Q 9 month · filed 2026-08-06 | -$9.86M derived: sum of 2 quarters · filed 2026-08-06 | -$15.77M derived: sum of 3 quarters · filed 2026-08-06 | -$27.95M S-1/A · filed 2026-08-06 | ||||
| 2024-03-31 | -$5.85M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-05-12 | -$11.76M derived: sum of 2 quarters · filed 2025-05-12 | -$23.94M 10-Q · filed 2025-05-12 | -$35.23M derived: sum of 4 quarters · filed 2025-05-12 | ||||
| 2023-12-31 | -$5.91M derived: 10-Q 6 month − 10-Q 3 month · filed 2025-02-11 | -$18.09M 10-Q · filed 2025-02-11 | -$29.37M derived: sum of 3 quarters · filed 2025-02-11 | -$41.11M derived: sum of 4 quarters · filed 2025-02-11 | ||||
| 2023-09-30 | -$12.18M 10-Q · filed 2024-11-13 | -$23.46M derived: sum of 2 quarters · filed 2024-11-13 | -$35.20M derived: sum of 3 quarters · filed 2024-11-13 | -$43.21M derived: sum of 4 quarters · filed 2024-11-13 | ||||
| 2023-06-30 | -$11.29M derived: 10-K 12 month − 10-Q 9 month · filed 2024-09-30 | -$23.02M derived: sum of 2 quarters · filed 2024-09-30 | -$31.03M derived: sum of 3 quarters · filed 2024-09-30 | -$40.25M 10-K · filed 2024-09-30 | ||||
| 2023-03-31 | -$11.74M derived: 10-Q 9 month − 10-Q 6 month · filed 2024-05-14 | -$19.75M derived: sum of 2 quarters · filed 2024-05-14 | -$28.97M 10-Q · filed 2024-05-14 | -$34.83M derived: sum of 4 quarters · filed 2024-05-14 | ||||
| 2022-12-31 | -$8.01M derived: 10-Q 6 month − 10-Q 3 month · filed 2024-02-13 | -$17.23M 10-Q · filed 2024-02-13 | -$23.09M derived: sum of 3 quarters · filed 2024-02-13 | -$28.98M derived: sum of 4 quarters · filed 2024-02-13 | ||||
| 2022-09-30 | -$9.22M 10-Q · filed 2023-11-08 | -$15.09M derived: sum of 2 quarters · filed 2023-11-08 | -$13.13M 10-Q · filed 2022-05-11 | -$25.68M derived: sum of 4 quarters · filed 2023-11-08 | ||||
| 2022-06-30 | -$5.87M derived: 10-K 12 month − 10-Q 9 month · filed 2023-08-16 | -$11.75M derived: sum of 2 quarters · filed 2023-08-16 | -$16.46M derived: sum of 3 quarters · filed 2023-08-16 | -$18.99M 10-K · filed 2023-08-16 | ||||
| 2022-03-31 | -$5.88M derived: 10-Q 9 month − 10-Q 6 month · filed 2023-05-12 | -$10.59M derived: sum of 2 quarters · filed 2023-05-12 | -$13.13M 10-Q · filed 2023-05-12 | -$20.13M derived: sum of 4 quarters · filed 2023-05-12 | ||||
| 2021-12-31 | -$4.71M derived: 10-Q 6 month − 10-Q 3 month · filed 2023-02-10 | -$7.24M 10-Q · filed 2023-02-10 | -$14.25M derived: sum of 3 quarters · filed 2023-02-10 | -$15.29M derived: sum of 4 quarters · filed 2023-02-10 | ||||
| 2021-09-30 | -$2.53M 10-Q · filed 2022-11-04 | -$9.54M derived: sum of 2 quarters · filed 2022-11-04 | -$3.44M 10-Q · filed 2022-05-11 | -$11.90M derived: sum of 4 quarters · filed 2022-11-04 | ||||
| 2021-06-30 | -$7.01M derived: 10-K 12 month − 10-Q 9 month · filed 2022-09-27 | -$8.05M derived: sum of 2 quarters · filed 2022-09-27 | -$9.37M derived: sum of 3 quarters · filed 2022-09-27 | -$10.45M 10-K · filed 2022-09-27 | ||||
| 2021-03-31 | -$1.04M derived: 10-Q 9 month − 10-Q 6 month · filed 2021-05-10 | -$2.36M derived: sum of 2 quarters · filed 2022-02-08 | -$3.44M 10-Q · filed 2021-05-10 | -$3.80M derived: sum of 4 quarters · filed 2022-02-08 | ||||
| 2020-12-31 | -$1.32M derived: 10-Q 6 month − 10-Q 3 month · filed 2022-02-08 | -$2.40M 10-Q · filed 2022-02-08 | -$2.76M derived: sum of 3 quarters · filed 2022-02-08 | -$3.16M derived: sum of 4 quarters · filed 2022-02-08 | ||||
| 2020-09-30 | -$1.08M 10-Q · filed 2021-11-10 | -$1.44M derived: sum of 2 quarters · filed 2021-11-10 | -$1.85M derived: sum of 3 quarters · filed 2021-11-10 | -$2.12M derived: sum of 4 quarters · filed 2021-11-10 | ||||
| 2020-06-30 | -$360.02K derived: 10-K 12 month − 10-Q 9 month · filed 2021-08-30 | -$761.41K derived: sum of 2 quarters · filed 2021-08-30 | -$1.04M derived: sum of 3 quarters · filed 2021-08-30 | -$1.63M 10-K · filed 2021-08-30 | ||||
| 2020-03-31 | -$401.39K derived: 10-Q 9 month − 10-Q 6 month · filed 2021-05-10 | -$677.29K derived: sum of 2 quarters · filed 2021-05-10 | -$1.27M 10-Q · filed 2021-05-10 | -$1.90M derived: sum of 4 quarters · filed 2021-05-10 | ||||
| 2019-12-31 | -$275.90K derived: 10-Q 6 month − 10-Q 3 month · filed 2021-01-29 | -$866.82K 10-Q · filed 2021-01-29 | -$1.50M derived: sum of 3 quarters · filed 2021-01-29 | -$2.16M derived: sum of 4 quarters · filed 2021-01-29 | ||||
| 2019-09-30 | -$590.91K 10-Q · filed 2020-11-05 | -$1.22M derived: sum of 2 quarters · filed 2020-11-05 | -$1.88M derived: sum of 3 quarters · filed 2020-11-05 | -$2.65M derived: sum of 4 quarters · filed 2020-11-05 | ||||
| 2019-06-30 | -$631.69K derived: 10-K/A 12 month − 10-Q 9 month · filed 2020-08-07 | -$1.29M derived: sum of 2 quarters · filed 2020-08-07 | -$2.06M derived: sum of 3 quarters · filed 2020-08-07 | -$2.50M 10-K/A · filed 2020-08-07 | ||||
| 2019-03-31 | -$658.87K derived: 10-Q 9 month − 10-Q 6 month · filed 2020-05-13 | -$1.43M derived: sum of 2 quarters · filed 2020-05-13 | -$1.87M 10-Q · filed 2020-05-13 | -$2.08M derived: sum of 4 quarters · filed 2020-05-13 | ||||
| 2018-12-31 | -$769.13K derived: 10-Q 6 month − 10-Q 3 month · filed 2020-02-13 | -$1.21M 10-Q · filed 2020-02-13 | -$1.42M derived: sum of 3 quarters · filed 2020-02-13 | -$1.47M derived: sum of 4 quarters · filed 2020-02-13 | ||||
| 2018-09-30 | -$441.88K 10-Q · filed 2019-11-19 | -$651.16K derived: sum of 2 quarters · filed 2019-11-19 | -$699.91K derived: sum of 3 quarters · filed 2019-11-19 | -$859.79K derived: sum of 4 quarters · filed 2019-11-19 | ||||
| 2018-06-30 | -$209.28K derived: 10-K 12 month − 10-Q 9 month · filed 2019-09-27 | -$258.02K derived: sum of 2 quarters · filed 2019-09-27 | -$417.90K derived: sum of 3 quarters · filed 2019-09-27 | -$621.34K 10-K · filed 2019-09-27 | ||||
| 2018-03-31 | -$48.74K derived: 10-Q 9 month − 10-Q 6 month · filed 2019-05-10 | -$208.62K derived: sum of 2 quarters · filed 2019-05-10 | -$412.06K 10-Q · filed 2019-05-10 | -$537.23K derived: sum of 4 quarters · filed 2019-05-10 | ||||
| 2017-12-31 | -$159.88K derived: 10-Q 6 month − 10-Q 3 month · filed 2019-02-12 | -$363.32K 10-Q · filed 2019-02-12 | -$363.32K 10-Q · filed 2018-02-14 | -$488.49K derived: sum of 3 quarters · filed 2019-02-12 | -$757.21K derived: sum of 4 quarters · filed 2019-02-12 | |||
| 2017-09-30 | -$203.44K 10-Q · filed 2018-11-14 | -$203.44K 10-Q · filed 2017-11-08 | -$328.61K derived: sum of 2 quarters · filed 2018-11-14 | -$597.33K derived: sum of 3 quarters · filed 2018-11-14 | -$699.04K derived: sum of 4 quarters · filed 2018-11-14 | |||
| 2017-06-30 | -$125.17K derived: 10-K 12 month − 10-Q 9 month · filed 2018-10-05 | -$393.89K derived: sum of 2 quarters · filed 2018-10-05 | -$495.60K derived: sum of 3 quarters · filed 2018-10-05 | -$623.62K 10-K · filed 2018-10-05 | ||||
| 2017-03-31 | -$268.72K derived: 10-Q 9 month − 10-Q 6 month · filed 2018-05-14 | -$370.43K derived: sum of 2 quarters · filed 2018-05-14 | -$498.45K 10-Q · filed 2018-05-14 | -$498.45K 10-Q · filed 2017-05-09 | -$617.84K derived: sum of 4 quarters · filed 2018-05-14 | |||
| 2016-12-31 | -$101.71K derived: 10-Q 6 month − 10-Q 3 month · filed 2018-02-14 | -$229.72K 10-Q · filed 2018-02-14 | -$349.12K derived: sum of 3 quarters · filed 2018-02-14 | -$365.43K derived: sum of 4 quarters · filed 2018-02-14 | ||||
| 2016-09-30 | -$128.01K 10-Q · filed 2017-11-08 | -$247.41K derived: sum of 2 quarters · filed 2017-11-08 | -$263.72K derived: sum of 3 quarters · filed 2017-11-08 | -$279.68K derived: sum of 4 quarters · filed 2017-11-08 | ||||
| 2016-06-30 | -$119.39K derived: 10-K 12 month − 10-Q 9 month · filed 2017-08-24 | -$135.71K derived: sum of 2 quarters · filed 2017-08-24 | -$151.67K derived: sum of 3 quarters · filed 2017-08-24 | -$153.63K 10-K · filed 2017-08-24 | -$163.63K 10-K · filed 2016-09-28 | |||
| 2016-03-31 | -$16.31K derived: 10-Q 9 month − 10-Q 6 month · filed 2017-05-09 | -$32.27K derived: sum of 2 quarters · filed 2017-05-09 | -$34.24K 10-Q · filed 2017-05-09 | -$45.29K derived: sum of 4 quarters · filed 2017-05-09 | ||||
| 2015-12-31 | -$15.96K derived: 10-Q 6 month − 10-Q/A 3 month · filed 2017-02-07 | -$17.93K 10-Q · filed 2017-02-07 | -$28.98K derived: sum of 3 quarters · filed 2017-02-07 | -$38.51K derived: sum of 4 quarters · filed 2017-02-07 | ||||
| 2015-09-30 | -$1.97K 10-Q/A · filed 2017-01-19 | -$13.02K derived: sum of 2 quarters · filed 2017-01-19 | -$22.55K derived: sum of 3 quarters · filed 2017-01-19 | -$52.63K derived: sum of 4 quarters · filed 2017-01-19 | ||||
| 2015-06-30 | -$11.05K derived: 10-K 12 month − 10-Q 9 month · filed 2016-09-28 | -$20.59K derived: sum of 2 quarters · filed 2016-09-28 | -$50.67K derived: sum of 3 quarters · filed 2016-09-28 | -$65.38K 10-K · filed 2016-09-28 | ||||
| 2015-03-31 | -$9.53K derived: 10-Q 9 month − 10-Q 6 month · filed 2016-05-23 | -$39.61K derived: sum of 2 quarters · filed 2016-05-23 | -$54.33K 10-Q · filed 2016-05-23 | -$66.72K derived: sum of 4 quarters · filed 2016-05-23 | ||||
| 2014-12-31 | -$30.08K derived: 10-Q 6 month − 10-Q 3 month · filed 2016-02-16 | -$44.80K 10-Q · filed 2016-02-16 | -$57.19K derived: sum of 3 quarters · filed 2016-02-16 | -$118.76K derived: sum of 4 quarters · filed 2016-02-16 | ||||
| 2014-09-30 | -$14.72K 10-Q · filed 2015-11-13 | -$27.11K derived: sum of 2 quarters · filed 2015-11-13 | -$88.68K derived: sum of 3 quarters · filed 2015-11-13 | -$127.70K derived: sum of 4 quarters · filed 2015-11-13 | ||||
| 2014-06-30 | -$12.39K derived: 10-K 12 month − 10-Q 9 month · filed 2015-10-01 | -$73.96K derived: sum of 2 quarters · filed 2015-10-01 | -$112.98K derived: sum of 3 quarters · filed 2015-10-01 | -$172.83K 10-K · filed 2015-10-01 | ||||
| 2014-03-31 | -$61.57K derived: 10-Q 9 month − 10-Q 6 month · filed 2015-05-11 | -$100.59K derived: sum of 2 quarters · filed 2015-05-11 | -$160.44K 10-Q · filed 2015-05-11 | -$162.95K 10-Q · filed 2014-05-09 | ||||
| 2013-12-31 | -$39.02K derived: 10-Q 6 month − 10-Q 3 month · filed 2015-02-05 | -$98.87K 10-Q · filed 2015-02-05 | -$101.38K 10-Q · filed 2014-01-29 | |||||
| 2013-09-30 | -$59.85K 10-Q · filed 2014-11-13 | -$62.36K 10-Q · filed 2013-11-13 | ||||||
| 2013-06-30 | -$2.51K 10-K · filed 2014-09-24 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Aspire Biopharma Holdings, Inc. (ASBP) | United States | $0.012B | -0.60 |
| ADIAL PHARMACEUTICALS, INC. (ADIL) | United States | $0.012B | |
| Phio Pharmaceuticals Corp. (PHIO) | United States | $0.012B | -0.92 |
| Tempest Therapeutics, Inc. (TPST) | United States | $0.013B | |
| Scienture Holdings, Inc. (SCNX) | United States | $0.012B | -0.38 |
| KIORA PHARMACEUTICALS INC (KPRX) | United States | $0.012B | |
| Dare Bioscience, Inc. (DARE) | United States | $0.011B | |
| AEON Biopharma, Inc. (AEON) | United States | $0.013B | -0.36 |
| MUSTANG BIO, INC. (MBIO) | United States | $0.013B | |
| Vistagen Therapeutics, Inc. (VTGN) | United States | $0.013B | -0.14 |